Internal Medicine, Hematology & Oncology · Nashville, TN
NPI
1942384821
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 936-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
366 services
Medicare patients, 2024
134
Average age 73
Drug cost, 2024
$2.3M
481 prescriptions
Company payments, 2025
$17.02
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sally York was code 99214 (office e&m - established), 121 times for 68 patients. In total Sally York billed 366 services in 11 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 121 | 68 | $67.27 | $8,139 |
| 99215 Office E&M - Established | Facility | 81 | 48 | $109.45 | $8,865 |
| 99213 Office E&M - Established | Facility | 57 | 45 | $46.66 | $2,660 |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 19 | $60.59 | $3,211 |
| 99238 Hospital Discharge Management | Facility | 16 | 15 | $62.68 | $1,003 |
| 99222 Hospital E&M - Initial | Facility | 15 | 14 | $101.12 | $1,517 |
By year: 2022 $45K for 512 services; 2023 $36K for 409 services; 2024 $28K for 366 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sally York prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 104 prescriptions and refills. In total Sally York wrote 481 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 104 | 105 | 12 | $1.7M |
| Levothyroxine Sodium Generic | 33 | 59 | Under 11 | $115 |
| Eliquis Apixaban | 32 | 66 | Under 11 | $41K |
| Ondansetron Hcl Generic | 19 | 19 | Under 11 | $180 |
| Omeprazole Generic | 18 | 44 | Under 11 | $321 |
| Prochlorperazine Maleate Generic | 17 | 17 | 11 | $378 |
| Ventolin Hfa Albuterol Sulfate | 16 | 16 | Under 11 | $566 |
| Tepmetko Tepotinib Hcl | 15 | 15 | Under 11 | $232K |
| Krazati Adagrasib | 13 | 13 | Under 11 | $169K |
| Clindamycin Phosphate Generic | 13 | 13 | Under 11 | $203 |
| Gefitinib Generic | 13 | 13 | Under 11 | $40K |
| Mirtazapine Generic | 11 | 19 | Under 11 | $226 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 11 | 11 | Under 11 | $4,807 |
Brand drugs: 225 claims; generic drugs: 256 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sally York $17.02 ($17.02 in general payments such as food, travel and fees) from 3 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $17.02.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $17.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.